The role of leptin in obesity and diabetes mellitus in dog

Detalhes bibliográficos
Autor(a) principal: Santos, Patrícia Isabel Cunha
Data de Publicação: 2014
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.26/16785
Resumo: Canine obesity is a serious breeding and health issue. Recent studies reported that 34-59% of dogs visiting veterinary are overweight and 5-20% are obese. Recent studies have shown that during the development of obesity there is several alterations at the cellular and molecular levels that contribute to the secretion of local and systemic molecules, called adipokines. These molecules contribute to the existence of a chronic low grade inflammatory state, to angiogenesis, to the control of appetite and satiety and to the control of the glucose and lipid metabolism. Together, these alterations may explain the reduced life span of obese animals and the development of several pathologies. One of main adipokines is leptin that plays a key role in the regulation of body weight, energy balance and feeding behaviour. Leptin is mainly regulated by adiposity, existing a positive correlation between the degree of adiposity and the plasma leptin concentration. In addition to adiposity, others factors regulate the leptin production such as insulin, glucocorticoids, endotoxin, and cytokines. Due to the contribution of leptin to the metabolism of glucose and lipids, several studies suggested that it may to establish an association between obesity, insulin resistance and ultimately diabetes. In fact, in humans the occurrence of obesity, dyslipidaemia and hypertension has been long associated to the development of insulin resistance and diabetes. However, the association between canine obesity and diabetes is not well understood, and there is no consensus whether obesity induces diabetes. Considering that obesity and diabetes reduce life span and the mechanisms underlying its development are not clearly understood, in this article we review the current knowledge on the association between obesity, diabetes and leptin.
id RCAP_685e11a9fd6d561637c10f01c53bb1a3
oai_identifier_str oai:comum.rcaap.pt:10400.26/16785
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling The role of leptin in obesity and diabetes mellitus in dogObesityLeptinInsulin resistanceObesidadeDiabetes mellitusLeptinaResistência à insulinaCanine obesity is a serious breeding and health issue. Recent studies reported that 34-59% of dogs visiting veterinary are overweight and 5-20% are obese. Recent studies have shown that during the development of obesity there is several alterations at the cellular and molecular levels that contribute to the secretion of local and systemic molecules, called adipokines. These molecules contribute to the existence of a chronic low grade inflammatory state, to angiogenesis, to the control of appetite and satiety and to the control of the glucose and lipid metabolism. Together, these alterations may explain the reduced life span of obese animals and the development of several pathologies. One of main adipokines is leptin that plays a key role in the regulation of body weight, energy balance and feeding behaviour. Leptin is mainly regulated by adiposity, existing a positive correlation between the degree of adiposity and the plasma leptin concentration. In addition to adiposity, others factors regulate the leptin production such as insulin, glucocorticoids, endotoxin, and cytokines. Due to the contribution of leptin to the metabolism of glucose and lipids, several studies suggested that it may to establish an association between obesity, insulin resistance and ultimately diabetes. In fact, in humans the occurrence of obesity, dyslipidaemia and hypertension has been long associated to the development of insulin resistance and diabetes. However, the association between canine obesity and diabetes is not well understood, and there is no consensus whether obesity induces diabetes. Considering that obesity and diabetes reduce life span and the mechanisms underlying its development are not clearly understood, in this article we review the current knowledge on the association between obesity, diabetes and leptin.A obesidade canina é uma grave questão de bem-estar. Estudos recentes mostram que 34-59% dos cães que visitam o veterinário têm excesso de peso e 5-20% são considerados obesos. Estudos recentes mostram que, durante o desenvolvimento da obesidade há várias alterações a nível celular e molecular que contribuem para a secreção de moléculas locais e sistémicas, chamadas adipocinas. Estas moléculas contribuem para a existência de um estado inflamatório crónico, para a angiogénese, para o controlo do apetite e saciedade e para o controlo do metabolismo da glucose e dos lípidos. Em conjunto, estas alterações podem explicar a redução do tempo de vida dos animais obesos e o desenvolvimento de várias patologias. Uma das principais adipocinas é a leptina que desempenha um papel fundamental na regulação do peso corporal, balanço energético e comportamento alimentar. A leptina é regulada principalmente pela adiposidade, existindo uma correlação positiva entre o grau de adiposidade e a concentração de leptina no plasma. Além da adiposidade, outros factores regulam a produção de leptina, tais como a insulina, os glucocorticóides, endotoxinas e citoquinas. Devido à contribuição da leptina para o metabolismo da glicose e dos lípidos, vários estudos sugerem que esta adipocina pode estabelecer uma associação entre obesidade, resistência à insulina e, finalmente, diabetes. De facto, nos humanos a ocorrência de obesidade, dislipidemia e hipertensão têm sido associados com o desenvolvimento de resistência à insulina e com a diabetes. No entanto, a associação entre a obesidade canina e diabetes não é bem compreendida, e não há consenso se a obesidade induz diabetes. Considerando que a obesidade e a diabetes reduzem o tempo de vida e os mecanismos subjacentes ao seu desenvolvimento não são claramente compreendidos, neste artigo vamos rever o conhecimento atual sobre a associação entre obesidade, diabetes e leptina.Carmo, Anália Georgina VitalBarros, Luís Carlos MeirelesRepositório ComumSantos, Patrícia Isabel Cunha2016-12-14T16:26:00Z2014-06-05T00:00:00Z2014-06-05T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10400.26/16785201097400eng201097400info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-09-05T13:56:46Zoai:comum.rcaap.pt:10400.26/16785Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:11:18.473682Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv The role of leptin in obesity and diabetes mellitus in dog
title The role of leptin in obesity and diabetes mellitus in dog
spellingShingle The role of leptin in obesity and diabetes mellitus in dog
Santos, Patrícia Isabel Cunha
Obesity
Leptin
Insulin resistance
Obesidade
Diabetes mellitus
Leptina
Resistência à insulina
title_short The role of leptin in obesity and diabetes mellitus in dog
title_full The role of leptin in obesity and diabetes mellitus in dog
title_fullStr The role of leptin in obesity and diabetes mellitus in dog
title_full_unstemmed The role of leptin in obesity and diabetes mellitus in dog
title_sort The role of leptin in obesity and diabetes mellitus in dog
author Santos, Patrícia Isabel Cunha
author_facet Santos, Patrícia Isabel Cunha
author_role author
dc.contributor.none.fl_str_mv Carmo, Anália Georgina Vital
Barros, Luís Carlos Meireles
Repositório Comum
dc.contributor.author.fl_str_mv Santos, Patrícia Isabel Cunha
dc.subject.por.fl_str_mv Obesity
Leptin
Insulin resistance
Obesidade
Diabetes mellitus
Leptina
Resistência à insulina
topic Obesity
Leptin
Insulin resistance
Obesidade
Diabetes mellitus
Leptina
Resistência à insulina
description Canine obesity is a serious breeding and health issue. Recent studies reported that 34-59% of dogs visiting veterinary are overweight and 5-20% are obese. Recent studies have shown that during the development of obesity there is several alterations at the cellular and molecular levels that contribute to the secretion of local and systemic molecules, called adipokines. These molecules contribute to the existence of a chronic low grade inflammatory state, to angiogenesis, to the control of appetite and satiety and to the control of the glucose and lipid metabolism. Together, these alterations may explain the reduced life span of obese animals and the development of several pathologies. One of main adipokines is leptin that plays a key role in the regulation of body weight, energy balance and feeding behaviour. Leptin is mainly regulated by adiposity, existing a positive correlation between the degree of adiposity and the plasma leptin concentration. In addition to adiposity, others factors regulate the leptin production such as insulin, glucocorticoids, endotoxin, and cytokines. Due to the contribution of leptin to the metabolism of glucose and lipids, several studies suggested that it may to establish an association between obesity, insulin resistance and ultimately diabetes. In fact, in humans the occurrence of obesity, dyslipidaemia and hypertension has been long associated to the development of insulin resistance and diabetes. However, the association between canine obesity and diabetes is not well understood, and there is no consensus whether obesity induces diabetes. Considering that obesity and diabetes reduce life span and the mechanisms underlying its development are not clearly understood, in this article we review the current knowledge on the association between obesity, diabetes and leptin.
publishDate 2014
dc.date.none.fl_str_mv 2014-06-05T00:00:00Z
2014-06-05T00:00:00Z
2016-12-14T16:26:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/16785
201097400
url http://hdl.handle.net/10400.26/16785
identifier_str_mv 201097400
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 201097400
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799129983512215552